2021

2021

ACHIEVE CLEAR CELL RENAL CELL CARCINOMA (CCRCC) CURES THROUGH DUAL-TARGETED FINE-TUNED IMMUNE RESTORING (DFIR) CAR-T CELL THERAPY

Wang, Y.;Buck, A.;Grimaud, M.;Kodangattil, S.;Razimbaud, C.;Fayed, A.;Chang, M. R.;Culhane, A.;Braun, D.;Choueiri, T. K.;Wu, C.;Wei, K.;Chan, L. L.;Piel, B. P.;Ivanova, E.;Paweletz, C. P.;Barbie, D.;Jenning, R.;Ficial, M.;Sticco-Ivins, M.;Signoretti, S.;Freeman, G. J.;Zhu, Q.;Marasco, W.; (2021) ACHIEVE CLEAR CELL RENAL CELL CARCINOMA (CCRCC) CURES THROUGH DUAL-TARGETED FINE-TUNED IMMUNE RESTORING (DFIR) CAR-T CELL THERAPY. Cytotherapy